Skip to main content
. Author manuscript; available in PMC: 2022 Feb 26.
Published in final edited form as: Vaccine. 2021 Sep 14;39(42):6302–6307. doi: 10.1016/j.vaccine.2021.08.099

Table 1.

Pre-intervention characteristics of the study population in each site.

Intervention
% (95% CI)
Comparison
% (95% CI)
Age (years)
 Under 5 5.2 (5.1, 5.4) 5.5 (5.4, 5.7)
 5–14 10.6 (10.4, 10.8) 13.5 (13.3, 13.8)
 15–17 3.1 (3.0, 3.2) 4.2 (4.0, 4.3)
 18–64 66.0 (65.6, 66.4) 62.2 (61.7, 62.6)
 65 and over 15.0 (14.7, 15.4) 14.6 (14.1, 15.0
Sex
 Female 53.8 (53.5, 54.0) 52.8 (52.5, 53.1)
 Male 46.2 (45.9, 46.5) 47.2 (46.9, 47.5)
Race
 Asian 14.2 (13.7, 14.6) 19.3 (18.9, 19.8)
 Black / African American 28.2 (27.7, 28.8) 20.2 (19.5, 20.8
 Hawaiian / Pacific Islander 0.5 (0.4, 0.5) 0.9 (0.8, 1.0
 Native American 0.4 (0.3, 0.4) 0.4 (0.4, 0.5)
 Multiracial 1.2 (1.1, 1.2) 1.1 (1.0, 1.2
 White 35.2 (34.7, 35.7) 29.5 (29.0, 30.1)
 Race not recorded 20.4 (19.9, 20.8 28.5 (28.0, 29.1)
Hispanic Ethnicity a 30.5 (29.9, 31.2 43.0 (42.2, 43.7)
MediCAL enrollee 4.4 (4.2, 4.6) 6.7 (6.4, 7.0)
Subsidized KPNC insurance 1.0 (0.9, 1.1 1.5 (1.4, 1.7
Primary language is not English b 12.0 (11.7, 12.4) 14.1 (13.7, 14.6)

Includes data for 101,761 Kaiser Permanente Northern California patients between September 1, 2013 and August 31, 2014.

a

Includes data for 61,847 Kaiser Permanente Northern California with recorded Hispanic ethnicity.

b

Includes data for 100,492 Kaiser Permanente Northern California with recorded primary language.